A multi-scale semi-mechanistic CK/PD model for CAR T-cell therapy

Publication of new article co-authored by Differentia's CEO, Dr. Kas Subramanian PhD, showing detailed results for modeling of the CAR T cell response, a semi-mechanistic model to explore variability in response due to patient- and drug-specific properties: A multi-scale semi-mechanistic CK/PD model for CAR T-cell therapy.